Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference44 articles.
1. Kieffer TJ, Habener JL. The glucagon-like peptides. Endocr Rev 1999, 20: 876–913.
2. Drucker DJ. The biology of incretin hormones. Cell Metab 2006, 3: 153–65.
3. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007, 87: 1409–39.
4. Novo Nordisk. Liraglutide (injection) for the treatment of patients with type 2 diabetes. NDA 22-341. Briefing document. Endocrine and Metabolic Drug Advisory Committee, 2 April 2009. http://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/endocrinologicandmetabolicdrugsadvisorycommittee/ucm148659.pdf . Accessed January 4, 2012.
5. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35: 1364–79.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献